Actively Recruiting

Age: 0 - 30Years
All Genders
NCT04968834

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

Led by Dana-Farber Cancer Institute · Updated on 2025-06-12

300

Participants Needed

8

Research Sites

624 weeks

Total Duration

On this page

Sponsors

D

Dana-Farber Cancer Institute

Lead Sponsor

C

Charles H. Hood Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research study is a genomic profiling and repository study for children and young adults who have leukemia, myelodysplastic syndrome (MDS) or myeloproliferative syndrome (MPS). Genes are the part of cells that contain the instructions which tell cells how to make the right proteins to grow and work. Genes are composed of DNA letters that spell out these instructions. Genomic profiling helps investigators understand why the disease develops and the instructions that led to its development. Understanding the genetic factors of the disease can also help investigator understand why the disease of some people can respond to certain therapies differently than others. The genomic profiling will be performed using bone marrow and blood samples that either have already been obtained during a previous clinical procedure or will be obtained at the time of a scheduled clinical procedure. Studying the genetic information in the cells of these samples will provide information about the origin, progression, and treatment of leukemia and myeloproliferative syndromes and myelodysplastic syndrome. Storing the bone marrow and blood samples will allow for additional research and genomic assessments to be performed in the future.

CONDITIONS

Official Title

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

Who Can Participate

Age: 0 - 30Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age: birth to less than 30 years old
  • Diagnosis of acute leukemia, chronic leukemia, MDS/AML, myelodysplastic syndrome, or myeloproliferative syndromes, either newly diagnosed or relapsed/refractory
  • Histologic confirmation of leukemia, myelodysplastic syndrome, or myeloproliferative syndrome at diagnosis or recurrence
  • Sufficient sample available for genomic profiling or planned bone marrow aspirate or blood draw expected to provide minimum specimen for testing
Not Eligible

You will not qualify if you...

  • Insufficient leukemia or MDS specimen available for profiling from diagnosis or recurrence
  • Bone marrow evaluations not planned for clinical care
  • Peripheral blast percentage less than 20%
  • Clinical blood draw not planned

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Connecticut Children's Medical Center

Hartford, Connecticut, United States, 06106

Actively Recruiting

2

Maine Medical Center

Portland, Maine, United States, 04102

Actively Recruiting

3

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Active, Not Recruiting

4

Dana Farber Cancer Institute

Boston, Massachusetts, United States, 02215

Active, Not Recruiting

5

Dartmouth-Hitchcock

Lebanon, New Hampshire, United States, 03756

Actively Recruiting

6

Albany Medical Center

Albany, New York, United States, 12208

Actively Recruiting

7

Lifespan Cancer Institute

Providence, Rhode Island, United States, 02903

Actively Recruiting

8

University of Vermont Medical Center

Burlington, Vermont, United States, 05401

Actively Recruiting

Loading map...

Research Team

Y

Yana Pikman, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here